Table 2.
Variable
|
Young
|
Old
|
Studies
|
|
P
value
|
||
No. (% of total) | 4195 | 84.1% | 796 | 15.9% | 8 | ||
n | % | n | % | n | % | ||
Gender | < 0.001 | ||||||
Male | 3572 | 85.1 | 623 | 78.3 | |||
Female | 520 | 12.4 | 132 | 16.6 | |||
Unknown | 103 | 2.5 | 41 | 5.2 | 1 | 12.5 | |
Charlson comorbidity index | 0.058 | ||||||
0 | 202 | 4.8 | 38 | 4.8 | |||
1 | 90 | 2.1 | 28 | 3.5 | |||
2 | 65 | 1.5 | 23 | 2.9 | |||
3 | 0 | 0.0 | 0 | 0.0 | |||
4 | 0 | 0.0 | 0 | 0.0 | |||
5 | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 3838 | 91.5 | 707 | 88.8 | 7 | 87.5 | |
Respiratory comorbidity | 0.272 | ||||||
Yes | 43 | 1.0 | 8 | 1.0 | |||
No | 361 | 8.6 | 104 | 13.1 | |||
Unknown | 3791 | 90.4 | 684 | 85.9 | 6 | 75.0 | |
Cardiac/Cardiovascular comorbidity | 0.244 | ||||||
Yes | 88 | 2.1 | 28 | 3.5 | |||
No | 316 | 7.5 | 84 | 10.6 | |||
Unknown | 3791 | 90.4 | 684 | 85.9 | 6 | 75.0 | |
Diabetes mellitus | 0.005 | ||||||
Yes | 17 | 0.4 | 10 | 1.3 | |||
No | 316 | 7.5 | 60 | 7.5 | |||
Unknown | 3862 | 92.1 | 726 | 91.2 | 6 | 75.0 | |
Renal insufficiency | 0.258 | ||||||
Yes | 1 | 0.0 | 2 | 0.3 | |||
No | 99 | 2.4 | 48 | 6.0 | |||
Unknown | 4095 | 97.6 | 746 | 93.7 | 7 | 87.5 | |
Liver cirrhosis | - | ||||||
Yes | 0 | 0.0 | 0 | 0.0 | |||
No | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 4195 | 100.0 | 796 | 100.0 | 8 | 100.0 | |
ASA | < 0.001 | ||||||
I | 164 | 3.9 | 13 | 1.6 | |||
II | 598 | 14.3 | 117 | 14.7 | |||
III | 194 | 4.6 | 66 | 8.3 | |||
IV | 6 | 0.1 | 0 | 0.0 | |||
V | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 3233 | 77.1 | 600 | 75.4 | 5 | 62.5 | |
Tumor location in the esophagus | 0.239 | ||||||
Cervical esophagus | 0 | 0.0 | 0 | 0.0 | |||
Upper third | 25 | 0.7 | 4 | 0.5 | |||
Middle third | 253 | 6.6 | 71 | 8.9 | |||
Lower third | 79 | 2.1 | 14 | 1.8 | |||
Junction | 0 | 0.0 | 0 | 0.0 | |||
Cardia | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 0 | 0.0 | 0 | 0.0 | |||
Unknown1 | 3838 | 100.0 | 707 | 88.8 | 7 | 87.5 | |
Histological type | 0.022 | ||||||
Adenocarcinoma | 2956 | 70.5 | 597 | 75.0 | |||
Squamous cell carcinoma | 442 | 10.5 | 89 | 11.2 | |||
Other | 21 | 0.5 | 0 | 0.0 | |||
Unknown1 | 1 | 0.0 | 2 | 0.3 | |||
Unknown | 775 | 18.5 | 108 | 13.6 | 2 | 25.0 | |
cTNM | 0.039 | ||||||
0 | 56 | 1.3 | 4 | 0.5 | |||
I | 234 | 5.6 | 40 | 5.0 | |||
II | 525 | 12.5 | 94 | 11.8 | |||
III | 547 | 13.0 | 83 | 10.4 | |||
IV | 131 | 3.1 | 14 | 1.8 | |||
Unknown1 | 70 | 1.7 | 3 | 0.4 | |||
Unknown | 2632 | 62.7 | 558 | 70.1 | 4 | 50.0 | |
pTNM | 0.648 | ||||||
0 | 1 | 0.0 | 0 | 0.0 | |||
I | 36 | 0.9 | 21 | 2.6 | |||
II | 20 | 0.5 | 9 | 1.1 | |||
III | 36 | 0.9 | 19 | 2.4 | |||
IV | 7 | 0.2 | 1 | 0.1 | |||
Unknown1 | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 4095 | 97.6 | 746 | 93.7 | 7 | 87.5 | |
Complete pathological response | 0.793 | ||||||
Yes | 60 | 1.4 | 16 | 2.0 | |||
No | 297 | 7.1 | 73 | 9.2 | |||
Unknown | 3838 | 91.5 | 707 | 88.8 | 7 | 87.5 | |
Neoadjuvant therapy | < 0.001 | ||||||
Yes | 714 | 17.0 | 120 | 15.1 | |||
No | 527 | 12.6 | 146 | 18.3 | |||
Unknown | 2954 | 70.4 | 530 | 66.6 | 3 | 37.5 | |
Resection type | - | ||||||
Transthoracic | 590 | 14.1 | 109 | 13.7 | |||
Transhiatal | 0 | 0.0 | 0 | 0.0 | |||
Unknown | 3605 | 85.9 | 687 | 86.3 | 6 | 75.0 | |
Surgical technique | 0.046 | ||||||
Ivor lewis | 472 | 11.3 | 98 | 12.3 | |||
McKeown | 17 | 0.4 | 1 | 0.1 | |||
Orringer | 0 | 0.0 | 0 | 0.0 | |||
Other | 101 | 2.4 | 10 | 1.3 | |||
Unknown | 3605 | 85.9 | 687 | 86.3 | 6 | 75.0 | |
Surgical approach | < 0.001 | ||||||
Open | 705 | 16.8 | 116 | 14.6 | |||
Minimally invasive | 525 | 12.5 | 129 | 16.2 | |||
Hybrid | 11 | 0.3 | 21 | 2.6 | |||
Unknown | 2954 | 70.4 | 530 | 66.6 | 3 | 37.5 |
Unknown: as stated in the included study. Only studies using an age threshold of 75 years to determine older patients are shown here. Regarding clinical and pathological tumor node metastasis stage, no particular tumor node metastasis edition was used.